dual-agonist comparative work
doi:10.1056/NEJMoa2028395 201
Compounded medications are only prescribed when medically necessary and tailored to meet the specific needs of the patient
Whether it is "better" depends on individual goals and tolerance
It is crucial to note that whilst these early findings are encouraging, GLP-1 agonists are not currently recommended or approved for AUD treatment by NICE, the MHRA, or other regulatory bodies
Functional nutrition brands are increasingly running usage and attitude studies, claims testing, and product format research to identify which delivery formats work best for appetite-suppressed consumers because the future of nutrition may depend not on flavor alone, but on convenience, digestibility, and perceived efficacy